CPT® Code 76937

Last Updated: February 2026 | Verified for 2026 CPT & CMS Payment Policy

Quick Reference:

• What 76937 means: Ultrasound guidance for vascular access that includes (1) ultrasound evaluation of potential access sites, (2) documentation of selected vessel patency, (3) concurrent real-time ultrasound visualization of vascular needle entry, and (4) permanent recording and reporting. It is an add-on service used with a qualifying primary vascular access procedure.
• Not “ultrasound used”: A generic statement that ultrasound was “used to assist” is commonly insufficient. Auditors expect documentation that the record explicitly supports all four descriptor elements (site evaluation, patency, real-time needle entry, permanent recording/report).
• Static marking does not qualify: Identifying a vessel and then inserting the needle without real-time visualization of needle entry does not meet the code descriptor requirements.
• NCCI and payer edits matter: Claims may deny when 76937 is reported with procedures where imaging guidance is considered integral or is bundled by policy/edit logic. Always check NCCI policy guidance and payer-specific edits for the primary procedure.
• MUE/units discipline: Medicare Medically Unlikely Edits (MUEs) limit the number of units payable on a date of service. If multiple distinct access events are billed, documentation must demonstrate distinct sites/lines/encounters consistent with payer rules and edits.
• 2026 payment context: CY 2026 introduces differentiated conversion factor updates tied to Advanced APM participation, which affects allowed amounts across all services billed under the MPFS.
• Documentation and image retention: Professional society guidance for point-of-care ultrasound emphasizes maintaining a clinical report and retaining images in a durable, retrievable format consistent with institutional policy and compliance expectations. CPT 76937 sits at the intersection of modern procedural safety and modern payer scrutiny. Clinically, real-time ultrasound guidance has moved vascular access from “best effort” landmark technique to an imaging-supported standard that reduces failed attempts and complications in many patient populations. Regulators and payers, however, treat 76937 as a highly specific add-on code: it is payable only when the record supports each element embedded in the descriptor, and it is vulnerable to denials when documentation is “thin,” when image retention is unclear, or when the primary procedure’s policy framework treats guidance as integral.

This 2026-focused guide is written for coders, clinicians, and revenue-cycle teams who need a defensible, audit-ready approach to reporting 76937 in professional and facility environments. It prioritizes what payers check: descriptor compliance, distinctness (when multiple access events occur), and consistency with CMS payment policy and NCCI logic.

1. Definition & Scope of CPT 76937

CPT 76937 is defined as ultrasound guidance for vascular access requiring: ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent real-time ultrasound visualization of vascular needle entry, with permanent recording and reporting. The code describes the guidance service—not the catheter insertion itself—and it is designed to be used when ultrasound is applied as a complete procedural guidance method rather than a quick “look” or non-documented assist.

The scope is intentionally narrow. The code is not intended for nonvascular ultrasound-guided needle placement (for example, aspiration of a fluid collection or injection into a joint), and it is not satisfied by marking the skin after identifying a vessel and then performing blind cannulation. The descriptor’s structure makes two principles payer-relevant:

• Completeness: each embedded descriptor element is part of the billed service; if one is missing, the service is not fully supported.
• Traceability: “permanent recording and reporting” implies there is a retrievable image (or images) and a report component in the medical record, enabling retrospective review. Practical compliance boundary: If your documentation does not clearly support (a) vessel patency documentation and (b) permanent recording/reporting, 76937 becomes difficult to defend on audit—even if ultrasound was clinically used. Build your templates so the descriptor elements are unavoidable.

2. When 76937 Is Reportable (Add-on Logic)

76937 is used as an add-on guidance service in conjunction with a qualifying vascular access procedure (for example, central venous access, arterial line placement, dialysis catheter work, or other vascular entry procedures, depending on the code set and payer rules). Add-on logic matters because payers expect that:

• There is a separately reportable primary procedure that establishes medical necessity and procedural context.
• 76937 represents a distinct imaging guidance service, not a duplicative charge for work already included in the primary code by valuation or policy edits. In 2026, the most common operational failure is not clinical misuse; it is policy mismatch—reporting 76937 when the payer’s bundling logic (often derived from NCCI or payer policy) treats ultrasound guidance as included with the primary service in that clinical context. Because these edit rules can differ by payer, the most defensible approach is to treat NCCI guidance as the baseline and then confirm payer-specific rules where applicable.

3. The Four Technical Requirements (What Must Be Documented)

The 76937 descriptor embeds four requirements. In real-world denials, payers commonly cite missing proof for one of these four rather than disputing that ultrasound was used. The standard is therefore “descriptor completeness” rather than “clinical plausibility.”

3.1 Ultrasound evaluation of potential access sites

The record should reflect an ultrasound assessment of one or more candidate vessels or access sites and should identify the selected target. Practically, this may include scanning the intended side and confirming an acceptable caliber and course; in difficult access it may include scanning alternative vessels (for example, right vs left internal jugular, or basilic vs brachial). The key is that the note reads like a deliberate evaluation rather than a single snapshot.

3.2 Documentation of selected vessel patency

Patency documentation is a high-yield audit target because it is explicitly required by the descriptor. “Patency” can be recorded using standard ultrasound descriptors appropriate to vessel type and clinical setting, such as:

• Compressible (common for veins where compressibility is used as a thrombus screen)
• Patent / no visible thrombus
• Adequate caliber / not thrombosed A denial-prone pattern is the absence of any patency statement paired with a generic “ultrasound guidance used” sentence. Because the descriptor explicitly requires patency documentation, payers can treat missing patency language as missing a core code element.

3.3 Concurrent real-time ultrasound visualization of needle entry

This is the most important clinical distinction between compliant guidance and “ultrasound assist.” The record should support that the needle entry into the vessel was visualized in real time (for example, “needle tip visualized entering the lumen under real-time ultrasound guidance”). Static marking before insertion is not equivalent to concurrent real-time visualization.

3.4 Permanent recording and reporting

“Permanent recording and reporting” means the ultrasound guidance service leaves an auditable footprint: a report component in the procedure note (or a separate imaging note, depending on workflow) and retained images. Specialty society guidance discussing POCUS reinforces the expectation that images and documentation are maintained in a durable format appropriate to the institution’s compliance and quality framework.

Common audit vulnerability: “Images saved” without stating where they are stored (for example, PACS, enterprise imaging, or approved secure archive) increases the risk that the payer will challenge whether recording was truly permanent/retrievable. Include the storage destination in the note when feasible.

4. Documentation Standards and Audit-Proofing

A defensible 76937 note is short but precise. The goal is not to write an essay; the goal is to explicitly satisfy every descriptor element in plain language while creating a record that can be retrieved years later. A good template makes it difficult to omit a required element.

4.1 Minimum documentation elements (audit-facing)

• Clinical context / indication: why vascular access is needed and why ultrasound was used (difficult access, obesity, prior line history, edema, shock, anticoagulation risk mitigation, etc.).
• Sites evaluated: which vessels or access sites were evaluated (at minimum the target vessel; ideally alternatives if clinically assessed).
• Patency statement: explicit documentation that the selected vessel was patent (or compressible, without thrombus, etc.).
• Real-time needle entry visualization: statement that needle entry was visualized concurrently in real time.
• Permanent recording and reporting: statement that images were recorded and archived, plus where stored when feasible.

4.2 Sample compliant documentation (structure you can reuse)

Example narrative: “Ultrasound was used to evaluate potential vascular access sites. The right internal jugular vein was assessed and selected based on size and patency; the vein was patent and compressible. Under concurrent real-time ultrasound guidance, the needle tip was visualized entering the venous lumen. Representative images documenting vessel patency and needle entry were permanently recorded and archived in the facility imaging system; findings are documented in this procedure note.”

4.3 Documentation pitfalls that drive denials

• Missing patency language: no statement that the vessel was patent/compressible/no thrombus.
• Ambiguous guidance method: “ultrasound used” without “real-time” and without needle entry visualization language.
• No evidence of permanent recording: no statement that images were archived, or uncertainty about whether images are retrievable.
• Policy mismatch with the primary code: guidance billed when the primary procedure is subject to edits/bundling that treat guidance as integral, leading to denials or recoupment.

5. 2026 Medicare Payment Context and Claim Mechanics

2026 is operationally important because CMS implemented policy updates that change allowed amounts across the MPFS through conversion factor updates and related payment adjustments. CMS also finalized differentiated payment updates based on participation status in Advanced APMs, which means conversion factor updates can differ by clinician category under MPFS policy in CY 2026.

5.1 Conversion factor split and why it matters for 76937

CPT 76937 is a relatively low-RVU add-on service, but it is high volume across emergency medicine, anesthesia, interventional radiology, vascular surgery, nephrology access work, and critical care. Small conversion factor differences therefore scale meaningfully at the system level. CMS’ CY 2026 MPFS communications and the AMA’s CY 2026 MPFS final rule analysis discuss how payment updates apply and the implications of the 2026 framework.

5.2 How to calculate allowed amounts (method)

Medicare allowed amounts are determined by RVUs (work, practice expense, malpractice), geographically adjusted by GPCIs, multiplied by the applicable conversion factor. Because 76937 may be billed in facility and non-facility settings and because add-on reporting interacts with the primary procedure’s setting, you should calculate allowed amounts using the locality and claim type that match the actual service. CMS program documents and MLN materials summarize MPFS policy updates and reinforce that payment is determined by MPFS methodology rather than by CPT descriptor alone.

Revenue-cycle control: Do not hard-code a single national “allowed amount” for 76937 into training materials. Use CMS fee schedule resources and your payer contract terms, because locality, facility/non-facility status, and component billing affect the payable amount.

6. NCCI Policy, MUEs, and Common Denial Patterns

The highest-yield compliance risk for 76937 is not that ultrasound guidance was unnecessary; it is that the billing structure conflicts with edits—either because 76937 is bundled into the primary service by policy or because the claim appears duplicative. CMS NCCI policy is the primary baseline reference for Medicare bundling logic and is widely used as a framework by many other payers.

6.1 NCCI: “Integral” imaging and code-pair logic

NCCI guidance emphasizes correct code selection and the principle that a code should be reported only when all services described by the code are performed, and it describes general bundling logic for radiology and related services. When a primary procedure’s valuation or policy framework includes imaging guidance, reporting an additional imaging guidance code may be denied or considered overbilling. The practical implication is that 76937 must be evaluated in the context of the specific primary code and payer policy/edit logic.

6.2 Medically Unlikely Edits (MUEs): units and repeat access events

CMS MUEs limit the number of units payable for a service on a single date of service, functioning as a frontline control against over-reporting. If your clinical scenario truly includes multiple distinct vascular access events that might justify multiple guidance services, your documentation must clearly differentiate the events (for example, different vascular beds, separate line placements, or separate encounters) consistent with payer rules. CMS’ public MUE resources describe the role of MUEs in claims processing.

6.3 Common denial narratives (what payers typically claim)

• “No documentation of patency.” The note lacks a patency statement.
• “No permanent recording/report.” There is no statement that images were retained, or the record cannot produce images when requested.
• “Not separately payable with the primary service.” The payer treats guidance as included for that primary code by policy/edit logic.
• “Units exceed MUE.” Multiple units billed without documentation supporting distinctness.

7. Modifiers and Distinct Access Events

Modifier strategy should never be the first step. The first step is to confirm whether 76937 is separately reportable with the primary procedure under the payer’s policy/edit rules. When multiple access events occur, modifiers may be required to communicate distinctness—but only when the clinical record truly supports separate reportable services and the payer recognizes the modifier for that purpose. CMS NCCI policy provides the conceptual framework for distinguishing separate services and avoiding incorrect unbundling.

In practice, “distinct access” scenarios that may arise include separate arterial and venous access placements, separate venous access sites for distinct devices, or a second access procedure in a separate encounter. Regardless of scenario, documentation should clearly establish:

• What was placed (device/line) and where (vessel/site)
• Why separate access was medically necessary
• How guidance was applied separately (separate evaluation/patency/needle entry visualization and recorded images) High-risk behavior: Using modifiers to “force pay” when the underlying record does not support distinct reportable services is a common audit trigger. Build distinctness first in documentation; modifiers follow documentation, not the reverse.

8. Comparisons: 76937 vs Other Guidance/Ultrasound Codes

The most frequent coding confusion is between vascular access guidance (76937) and general ultrasound guidance/needle placement codes. The cleanest decision rule is to anchor to what the needle is entering and what the descriptor requires.

9. Real-World Clinical Scenarios (2026 Documentation Examples)

Scenario 1: ICU central venous access with ultrasound guidance

Setting: ICU, urgent need for central access.

Clinical facts: Patient requires reliable venous access for vasoactive infusion and monitoring; prior difficult access history.

Documentation focus for 76937: Note evaluation of potential access sites, document selected vein patency (e.g., compressible/patent), state real-time needle entry visualization, and confirm images were permanently recorded and where archived.

Why this is defensible: Each descriptor element is explicitly documented, and image retention supports audit retrieval.

Scenario 2: ED peripheral difficult access requiring guided vascular entry

Setting: Emergency department, time-sensitive access.

Clinical facts: Edema/obesity and prior IV attempts make landmark approach unreliable.

Documentation focus: ED teams often document “US-guided IV” but omit patency and permanent recording. For 76937, the record must still explicitly support patency and permanent recording/reporting, not just “ultrasound used.”

Scenario 3: Dialysis access work where multiple candidate vessels are scanned

Setting: Outpatient vascular access center or hospital.

Clinical facts: Prior catheter history; concern for thrombosis/stenosis; need to identify a patent segment.

Documentation focus: Make the “evaluation of potential access sites” explicit (e.g., evaluated multiple candidate vessels), document patency, real-time needle entry, and retained images.

Compliance note: If multiple access events are billed on the same date, anticipate MUE scrutiny and ensure distinctness is clearly documented.

Scenario 4: Two distinct access events (arterial line + central venous line) on the same date

Setting: OR/ICU, hemodynamically unstable patient.

Clinical facts: Separate arterial monitoring line and separate venous catheter are placed.

Billing risk: Units/edits scrutiny is common; the record must show two distinct access procedures and, if guidance is billed separately, that the guidance service was independently performed and documented for each reportable event consistent with payer rules and edits.

10. Compliance Checklist (Copy/Paste)

CPT 76937 Documentation Checklist

• State that ultrasound was used to evaluate potential access sites (not just “used”).
• Identify the selected vessel and document patency (e.g., patent/compressible/no thrombus).
• Document concurrent real-time visualization of needle entry into the vessel.
• Document permanent recording and reporting (images saved/archived; include storage destination when feasible).
• Confirm 76937 is separately reportable with the primary procedure under payer policy/NCCI logic.
• If multiple units are billed, document distinct access events consistent with MUE/edit logic. Bottom line for 2026: 76937 remains highly reportable when it is truly performed as described and documented precisely, but it is increasingly denial-prone when documentation is generic, when image retention is unclear, or when payer edits treat guidance as integral to the primary procedure. Build descriptor-complete templates, align billing with NCCI/MUE expectations, and educate clinicians that “ultrasound was used” is not synonymous with “76937 is supported.”